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Abstract
The symptoms of schizophrenia are highly variable and include a variety of cognitive deficits,
including attentional deficit. These cognitive deficits may involve dopamine (DA) underactivity
in the prefrontal cortex (PFC) (Weinberger, Egan, Bertolino, Callicott, Mattay, Lipska, et al.,
2001). The purpose of this thesis was to test the hypothesis that reduced DA in the PFC alters
attention by examining the effects of reduced DA in the medial PFC (mPFC) of rats on a
sustained attention task. Rats in the DA-lesioned group were administered 6-hydroxydopamine
(6-OHDA) in the mPFC. Following 6-OHDA administration, rats in the DA-lesioned and shamlesioned group were trained to nose poke into a lit aperture for food reward in the 5-choice serial
reaction time task (5-CSRTT), a rodent analogue of the Continuous Performance Task used to
assess sustained attention in schizophrenics (Robbins, 2002). The 6-OHDA administration
resulted in depletions of both DA (33% of controls) and norepinephrine (NE) (50% of controls).
Rats’ performance was assessed by comparing the frequency of correct, incorrect, omitted, and
premature responses in testing conditions where the duration of stimulus in the 5-CSRTT was
randomly varied from 2.5 to 0.25 seconds. No significant differences between lesioned and
control rats were observed in any behavioral testing parameters. However, there was a trend
toward increased numbers of omissions and reduced correct responses seen in lesioned rats
especially at the shortest stimulus durations. The trend supports the hypothesis that reduced DA
in the PFC contributes to attentional dysfunction in schizophrenia. Future studies should examine
the behavioral effects of 6-OHDA lesions using larger sample sizes. Also, future studies should
examine rats’ 5-CSRTT performance at stimulus durations less than 0.25 seconds to further
explore the trend toward poorer performance seen in 6-OHDA lesioned rats.
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Five-Choice Serial Reaction Time Task Performance Following Catecholamine Depletion of
Rat Medial Prefrontal Cortex:
Implications for Attention Deficit in Schizophrenia
Schizophrenia is a disorder characterized by disorganized thoughts, hallucinations and
delusions, emotional disturbances, and cognitive deficits (Lewis, Hashimoto, & Volk, 2005). It is
believed to be a neurodevelopmental disorder (Rapoport, Addington, Frangou, & Psych, 2005),
with the onset of symptoms generally occurring during late adolescence through early adulthood
(Raedler, Knable, & Weinberger, 1998). Post-mortem analyses of the brains of schizophrenics
have revealed structural abnormalities such as decreased grey matter volume in the prefrontal
cortex (PFC) (Hashimoto, Volk, Eggan, Mirnics, Pierri, Sun, et al., 2003; Shenton, Dickey,
Frumin, & McCarley, 2001). The PFC is not fully developed until early adulthood (Krasnova,
Betts, Dada, Jefferson, Ladenheim, Becker, et al., 2007), which is also when schizophrenia is
typically diagnosed. This has led to the hypothesis that abnormal maturation and function of the
PFC may underlie emergence of the symptoms of schizophrenia (Finlay, 2001).
Schizophrenia is diagnosed in approximately 1% of the world’s population (Lewis, Cruz,
Eggan, & Erickson, 2004). Sensory disturbances and psychotic states are common features of the
illness. Due to the action of antipsychotic drugs, the most extensively studied neurotransmitter
system in relation to schizophrenia is the monoamine neurotransmitter dopamine (DA) (Guillin,
Abi-Dargham, & Laruelle, 2007). Antipsychotic drugs ameliorate psychotic symptoms by
blocking the action of DA at post-synaptic D2 receptors (Meisenzahl, Scheuerecker, Schmitt, &
Moller, 2007), which suggests that psychotic symptoms occur because of overstimulation of D2
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receptors. Likewise, drugs that increase DA release, such as amphetamine, can induce psychosis
and exacerbate the psychotic symptoms of schizophrenia (Abi-Dargham & Moore, 2003).
The relationship between excessive activity of DA and psychosis has given credence to
the hypothesis that perturbations in DA neurotransmission may underlie many of the symptoms
of schizophrenia (Tzschentke, 2001). However, in addition to symptoms of psychosis,
schizophrenics experience a range of cognitive deficits, including working memory and
sustained attention (Riehemann, Volz, Stutzer, Smesny, Gaser, & Sauer, 2001). These deficits
are generally not remedied by DA receptor antagonists (Radek, Kohlhaas, Rueter, & Mohler,
2010). Schizophrenics tend to display decreased cerebral blood flow in the PFC, which is
correlated with reduced DA metabolites in cerebral spinal fluid (Weinberger, Berman, &
Illowsky, 1988), a brain region critically involved in working memory and attention (Christakou,
Robbins, & Everitt, 2004; Goldman-Rakic, Muly, & Williams, 2000). This has led to the
hypothesis that reductions in DA neurotransmission in the PFC may underlie the attentional
deficits of schizophrenia (Weinberger et al., 2001).
To test this hypothesis, the present study explored the effects of disrupting DA
innervation of rat PFC on a sustained attention task modeled after the Continuous Performance
Task (CPT) (Rosvold, Mirsky, Sarason, Bransome, & Beck, 1956) that is used to assess
sustained attention in schizophrenics. Before presenting the thesis research itself, the following
sections will: 1) outline DA function in the PFC in relation to schizophrenia; 2) describe the
nature of cognitive impairment in schizophrenia; and 3) describe the task used to study neural
correlates of sustained attention in rodents.
Prefrontal Cortex Dopamine and Attention
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An optimal level of D1 receptor stimulation in healthy individuals is required for normal
working memory and attention (Goldman-Rakic, Muly, & Williams, 2000). In primates, both
over- and understimulation of D1 receptors in the PFC hinders performance in a working
memory task (Cai & Arnsten, 1997). Too little or too much DA activity, therefore, may
negatively affect working memory and attentional performance.
Lesions to the mPFC using quinolinic acid result in behavioral deficits in a 5-choice
serial reaction time task (Chudasama, Passetti, Rhodes, Lopian, Desai, & Robbins, 2003).
However, multiple types of neurons are destroyed by quinolinic acid lesions. This non-specific
lesion identifies a role of the mPFC but does not identify the effects of disruption to a particular
kind of neurotransmission within the mPFC.
Evidence for DA involvement in attention comes from pharmacological manipulations
demonstrating behavioral effects following direct mPFC D1 agonism and antagonism. This
manifested as both improved and hindered attentional performance depending on baseline
performance (Granon, Passetti, Thomas, Dalley, Everitt, & Robbins, 2000). Therefore, the
present study aimed to further explore the role of reduced DA on attention in rats using a
controlled DA manipulation.
Prefrontal Cortex Dopamine and Schizophrenia
Schizophrenics have reduced density of fibers immunoreactive for tyrosine hydroxlyase,
the rate-limiting enzyme involved in DA synthesis, in prefrontal cortical layers 3 and 6, (Akil,
Pierri, Whitehead, Edgar, Mohila, Sampson, & Lewis, 1999). Also, schizophrenics display
reduced dendritic spine density in post-mortem analyses of the PFC, which may be related to
decreases in DA innervation (Glantz & Lewis, 2000). In adult rats, DA depletion (>50%) of the
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ventral tegmental area (VTA) induced by the catecholamine neurotoxin 6-hydroxydopamine (6OHDA) results in decreased spine density of layer 5 pyramidal neurons of the mPFC (Wang &
Deutch, 2008). This suggests that abnormal DA neurotransmission may influence synaptic
structure, resulting in fewer synapses and impaired PFC function.
As noted earlier, schizophrenia may involve excess DA in subcortical structures, yet too
little DA in cortical regions (Knable & Weinberger, 1997; Guillin et al., 2007). Specifically, the
model involves hypoactivity of the mesocortical DA system, beginning in the VTA and
terminating in the PFC, paired with hyperactivity of the mesolimbic pathways, which originate in
the VTA and terminate in the nucleus accumbens, hippocampus, and amygdala. Mesolimbic DA
overactivity is believed to contribute to psychotic experiences (Goto & Grace, 2007), while
mesocortical hypoactivity may contribute to cognitive deficit, including sustained attention
(Meisenzahl et al., 2007).
Attentional Deficit in Schizophrenia
The CPT is used to study attentional deficits in schizophrenic patients (Rund, 1998). The
CPT involves rapidly presenting visual stimuli to subjects in a non-predictable arrangement of
continuously changing patterns, typically letters or numbers (Riccio, Reynolds, Lowe, & Moore,
2002). The classic paradigm involves designating the letter “X” as the target, presented within a
series of letters flashed for 1-2 seconds (Rosvold et al., 1956). When the target is detected,
subjects respond by pressing a lever. Increasing the complexity of the target adds an additional
level of difficulty (e.g., requiring that the letter “A” be paired with “X”; Riccio et al.). The
unpredictability of the stimulus presentation requires subjects to remain vigilant to changing task
requirements (Hazlett, Dawson, Schell, & Neuchterlein, 2001).
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Shortening the stimulus duration, adjusting the frequency of target presentation, and
manipulating perceptual aspects of the target (such as blurring or partially occluding) are
additional methods of increasing attentional challenge on the CPT (Riccio et al., 2002).
Cognitive deficits in schizophrenics become more apparent on tasks requiring elevated levels of
attention (Jazbec, Pantelis, Robbins, Weickert, Weinberger, & Goldberg, 2007), and
schizophrenics typically require a longer duration of stimulus presentation to perform at control
levels (Cattapan-Ludewig, Hilti, Ludewig, Vollenweider, & Feldon, 2005). Similar deficits are
seen in patients with frontal lobe damage, suggesting that poor performance on the CPT is
related to abnormal PFC function (Riccio et al.).
The 5-Choice Serial Reaction Time Task
The 5-choice serial reaction time task (5-CSRTT) is a rodent version of the CPT used to
assess attention in schizophrenic subjects (Robbins, 2002; see Figure 1). The task assesses an
animal’s ability to remain vigilant to an array of visual stimuli over a 30-minute test session
(Carli, Robbins, Evenden, & Everitt, 1983). In this task, rats maintain visual attention to an array
of five apertures located on one wall of a test chamber. One of these five apertures is lit on a
pseudorandom schedule for a short period of time; rats learn to poke their nose into the lighted
aperture to receive a food pellet from a dispenser on the opposite wall of the test chamber. This
task becomes especially challenging when the length of time that the aperture is lit is reduced.
By placing additional cognitive demands (e.g., shortening the stimulus duration, introducing a
noise distracter), the 5-CSRTT provides a method for systematically challenging sustained
attention in animals analogous to the CPT in humans.
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The 5-CSRTT engages DA pathways terminating in the rat mPFC (Dalley, Cardinal, &
Robbins, 2004; Muir, Everitt, & Robbins, 1996). Quinolinic acid lesions of the rat mPFC reduce
overall PFC neurotransmission and impair performance on the 5-CSRTT (Passetti, Levita, &
Robbins, 2003). Quinolinic acid lesions glutamatergic and GABAergic neurons, but does not
reduce tyrosine-hydroxylase-labeled axons in lesion sites (Schwarcz, Whetsell, & Mangano,
1983). The attention deficit caused by quinolinic acid is remedied by administration of a D2
receptor antagonist (Passetti, Levita, & Robbins, 2003). This suggests that the mPFC lesion
hinders performance because the DA system is disrupted. However, it is unclear where the DA
antagonist is acting in the brain to ameliorate deficits.
Antagonism of D1 receptors in the mPFC improves baseline performance in the 5CSRTT in unlesioned rats performing below the group median (Granon et al., 2000).
Performance-enhancing effects of dopaminergic pharmacological manipulations in the 5-CSRTT
suggest that this task assesses cognitive abilities that are dependent on the functional capacity of
the mesocortical pathway. Consequently, the 5-CSRTT will be used in the present study as a
behavioral paradigm for investigating the effects of neurochemical disruption to the DA system
on attentional processes in rodents.
Present Study
The present study explored the cognitive effects of insult to dopaminergic
neurotransmission in the PFC in the rat. Specifically, the effects of 6-OHDA administered into
the mPFC of rats during the early adulthood period (postnatal day 55) on performance in the 5CSRTT were assessed at adulthood.
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Method
Subjects
Male Sprague-Dawley rats (N = 12; Harlan Sprague-Dawley, Inc., Indianapolis, IN.)
were housed in pairs from arrival at postnatal day (PN) 37 until surgery. Rats were randomly
assigned to either a sham (n = 5) or lesion (n = 7) condition on the day of surgery. One of the rats
in the lesion condition did not recover from surgery; as a result, the study included n = 6 rats in
the lesion condition. Until the start of behavioral testing, rats were given free access to tap water
and standard rodent chow (Mazuri Rodent Chow, Minneapolis, MN) and were maintained on a
12:12 hour light/dark cycle with lights on at 7:00 AM. During behavioral testing, ad libitum
access to tap water was continued, but rats were food deprived to 80-85% of free-feeding body
weight relative to age-matched controls (~310 grams at start of testing). At all times, rats were
treated according to the NIH Guidelines for the Care and Use of Laboratory Animals and
Western Washington University’s local animal use committee.
Surgery
At PN 55 (body weight range 210-270 grams), each rat was given a systemic injection of
equithesin (3.0 ml/kg) 20 minutes prior to placement in the stereotax (David Kopf Instruments,
Models 900, 970, and 907, Turjunga, CA). Equithesin anesthesia was supplemented as needed
throughout the course of the surgery. The surgical procedure involved bilateral microinjections
of the 6-OHDA (MP Biomedicals, lot #5664J; 1.0 µg base/2 µl vehicle, dissolved in ascorbic
acid; 2 µl/hemisphere at a flow rate of 0.2 µl/min) or vehicle into the mPFC (+3.2
anteroposterior, ±0.8 mediolateral, and -3.2 dorsoventral from bregma; Paxinos & Watson,
1986). To reduce 6-OHDA destruction of norepinephrine (NE) terminals in the mPFC, the NE
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transporter antagonist desipramine hydrochloride (DMI; Sigma D3900-5G; 25 mg base/kg,
dissolved in saline immediately prior to use) was administered intraperitoneally 1 hour prior to
the 6-OHDA injections. Control subjects received an injection of saline, also delivered
intraperitoneally.
Immediately following surgery, animals were placed on a heating pad and monitored
until full recovery, and then individually housed for the duration of the study.
Behavioral Testing
Apparatus. Operant conditioning chambers (Model MED-NP9L-B1, Med. Associates Inc., St.
Albans, VT; 12.0" L x 9.5" W x 8.25" H) were used to assess sustained visual attention in the 5CSRTT (see Figure 1). Nose poking into one of nine apertures (2.5 cm2) located on one wall of
the chamber resulted in delivery of a 45 mg food pellet from a dispenser located on the opposite
wall. A house light located directly above the food receptacle was illuminated when rats
responded performed premature, incorrect, or omitted responses. A stainless steel grid floor was
situated above cob bedding, which was replaced prior to the start of each daily session. There
were two testing chambers; care was taken to ensure that rats were assigned to the same chamber
each day. The operant chambers were controlled by a Windows-based computer and interface
(MEDPC-IV; Med Associates Inc., St. Albans, VT) located outside of the testing room.
Protocol. Training in the 5-CSRTT began 2 weeks post-surgery. Food deprivation began the day
before the first training session; body weights were assessed prior to each operant session to
maintain animals at 80-85% of free-feeding weight. Rats reached this body weight after an
average of 3-4 days of limited food intake.
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Habituation Phase
The goal of habituation sessions was to acclimate each rat to the testing chamber and to
lead them to associate the light in the food receptacle with delivery of food reward. Animals
spent 2 days habituating to the testing box. Each habituation session lasted for 30 minutes.
During each habituation session, a light in the food receptacle was turned on for 30 seconds, and
shut off for the remaining 30 seconds of each 60-second period. If the rat failed to retrieve the
pellet within the allotted time period, the house light above the food receptacle was illuminated
for 5 seconds. The period of time during which a rat could obtain the food pellet once the light in
the receptacle was turned off is referred to as the limited hold period. The limited hold period
provided an opportunity for a rat to respond correctly even when the light stimulus had been
turned off.
Response-Shaping Phase
A 2-day response-shaping phase immediately followed the habituation phase. These
sessions were identical to the habituation sessions except that: 1) the shaping sessions lasted for
30 minutes or the completion of 100 trials; and 2) each rat had to poke its nose into the food
receptacle to trigger the delivery of a food pellet. During the response-shaping sessions, rats were
conditioned to perform a specific nose poke response to the light presented in the food
receptacle.
Aperture-Response Phase
Immediately after the response-shaping phase, the aperture-response phase was initiated.
During this phase, rats learned to nose poke into one of five apertures located on the wall
opposite the food receptacle, rather than into the food magazine. Each session during this phase
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lasted for 30 minutes or 100 complete trials. For each trial, a light was illuminated
pseudorandomly in one of the five apertures; each rat had to learn to nose poke into the lit
aperture. Rats learned to pay attention to the wall of apertures in order to correctly detect the
location of the lit aperture, and then to subsequently collect their food reward from the
receptacle. Once the food pellet was retrieved, a 5 second inter-trial interval commenced,
followed by initiation of the next trial.
When a rat had learned to respond correctly for at least 50 of 100 possible trials over a
30-minute session, the task difficulty was gradually increased by reducing the amount of time
that the stimulus aperture was lit on the next testing session. At the beginning of the apertureresponse phase, rats had 30 seconds to locate the illuminated aperture. As the rats acquired the
task during the aperture-response phase, the length of time that the aperture was illuminated was
reduced to a 2.5 second duration.
Probe Trial Phase
After a stable performance was achieved (less than 20% omissions; more than 80%
correct responses) at a 2.5 second stimulus duration over 2 consecutive testing sessions, rats
began the probe trial phase. During the probe trial phase, the length of stimulus presentation
during a given session was decreased from 2.5 seconds to one of four different durations (1.5,
1.0, 0.5, and 0.25 seconds), presented over the course of the next testing session on a
pseudorandom schedule. The 5-second limited hold period became especially important during
the probe trial phase, as the light in an aperture was only visible for a short amount of time. This
made the completion of a nose poke in an aperture while the stimulus was presented difficult, if
not impossible. Probe trials were not administered on consecutive testing days, meaning that
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each probe trial was separated by at least one day of testing at baseline parameters (2.5-second
stimulus duration).
Each rat was presented with each of the four different stimulus durations on three
different testing sessions, and each probe trial session continued for 30 minutes or the
completion of 100 trials.
Analysis. A correct response was defined as a nose poke into an illuminated aperture or during
the limited hold period that followed.
Additionally, several different types of error are assessed in the 5-CSRTT (see Figure 1;
Dalley, Cardinal, & Robbins, 2004). An incorrect response is a nose poke response into any of
the four apertures where the stimulus was not presented. A premature response is a nose poke
made during the inter-trial period (5 seconds) prior to the stimulus presentation. Lastly, an
omission occurs when no response is made during the period where the aperture is lit or the 5second limited hold period that immediately followed.
The frequency of correct responses, omitted responses, number incorrect, and number of
premature responses made was used to assess performance in lesioned and control rats.
Neurochemical Analyses
Animals were decapitated, their brains removed, and the mPFC rapidly dissected out. The
tissue was immediately flash-frozen on dry ice and stored at -80ºC. High pressure liquid
chromatography (HPLC) was used to assess the concentrations of dopamine (DA) and
norepinephrine (NE) in samples taken from the mPFC of each hemisphere.
High Pressure Liquid Chromatography. Tissue from a single hemisphere was placed in
microcentrifuge tubes containing 250 µl of 0.2 M hydrochloric acid, sonicated until

12
homogenous, and then spun at 14,000 rpm for 25 minutes. The liquid portion of the sample was
removed, placed in new microcentrifuge spin-X tubes, and spun at 10,000 rpm for an additional
10 minutes. Tissue samples were then frozen at -80ºC until processed using HPLC.
The mobile phase circulated through the HPLC system at a flow rate of 0.4 mL/minute,
and consisted of 75 mM sodium dihydrogen phosphate, 0.025 mM ETDA, 10% acetonitrile, 100
µl /L triethylamine, and 1.7 mM 1-octanesulfonic acid (sodium salt). The mobile phase was
vacuum filtered, and adjusted to a pH of 3.0 using 12 N phosphoric acid. A standard solution and
tissue samples was injected into an HPLC instrument using an autosampler (ESA Model 540,
Chelmsford, MA) and delivery system (ESA Model 580, Chelmsford, MA). In some cases, the
tissue samples were manually injected into the HPLC. The standard solution was composed of
10 µl each of aqueous DA, NE, DOPAC, HVA, and 5-HIAA in 10 mL 0.2 M HCl. Tissue
samples (20 µl) were injected following analysis of the standard solution. The analytical column
(15 cm x 3 mm x 3 µm; Supelco, Model Supelcosil™, Bellefonte, PA) was connected to a
coulometric detection system (ESA Coulochem II, Chelmsford, MA). Chromatograms were
analyzed on a PC using VARIAN Star Chromatography Workstation (Version 5).
Data Analysis
Each dependent measure (correct responses; omissions; incorrect responses; premature
responses) was assessed with repeated-measures ANOVAs across five stimulus durations (2.5,
1.5, 1.0, 0.5, and 0.25 seconds). Furthermore, a Pearson correlational coefficient was calculated
to determine if correct or omitted responses were related to degree of catecholamine depletion in
the mPFC.
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An independent-samples t-test was conducted in order to determine the extent of DA
depletion in the mPFC of 6-OHDA treated rats and sham controls. HPLC chromatographs were
quantified by establishing the peak height and base distance of retention time spikes for DA and
NE. The relative concentrations of neurotransmitters were calculated based on retention time
chromatographs calibrated from the standard solution.
Results
There were significant reductions in both DA and NE tissue content in 6-OHDA treated
animals relative to controls (for DA, (t(9) = -7.61, p < .001; for NE t(9) = 5.83, p < .001; see
Table 1). Administration of 6-OHDA in the mPFC reduced DA in the lesioned rats ranging from
between 16% and 62% of controls (average DA depletion to 33% of controls, S.E.M. = 7.77). NE
depletion was slightly less robust, ranging from 26% to 65% of controls (average NE depletion
to 50% of controls, S.E.M. = 6.29). A two-tailed Pearson correlational coefficient did not reveal a
significant association between NE and DA depletion in lesioned rats (r = .48, p = .34).
Manipulating task difficulty in the 5-CSRTT by shortening the length of stimulus
presentation resulted in similar behavioral changes in both lesioned and control animals. As the
stimulus duration was decreased, both groups of rats were less able to respond correctly and
there was a corresponding increase in the frequency of omitted, incorrect and premature
responses (see Tables 2-5).
Repeated-measures ANOVAs revealed significant overall effects of shortening the
stimulus duration in both 6-OHDA treated and control rats. As the stimulus duration decreased,
percent correct responses decreased in both groups [F (4, 36) = 64.30, p < .001; see Figure 2; for
raw data, see Table 1], and percent omissions increased [F (4, 36) = 60.11, p < .001; see Figure

14
3; for raw data, see Table 2]. Furthermore, shortened stimulus durations resulted in a significant
increase in the number of incorrect responses [F (4, 36) = 61.37, p < .001; see Figure 4], and the
number of premature responses [F (4, 36) = 31.86, p < .001; see Figure 5] in both groups.
The 6-OHDA treated rats tended toward increased omissions at four out of five stimulus
durations, and tended toward less correct at three out of five stimulus durations. However,
repeated-measures ANOVAs did not reveal a significant interaction of lesion x stimulus duration
on percent correct responses [F (4, 36) = 0.40, p = 0.81], or percent omitted responses [F (4, 36)
= 1.13, p = 0.36]. The number of incorrect responses did not differ significantly between groups
[F (4, 36) = 1.30, p = 0.29], nor did premature responses [F (4, 36) = 0.17, p = 0.95].
Furthermore, correlations between the degree of DA and NE depletion and number correct and
omitted were not significant at stimulus durations of 0.25, 0.5, 1.0, or 1.5 seconds (data not
shown).
Discussion
The catecholamine neurotoxin 6-OHDA administered into the mPFC of rats significantly
depleted DA, and to a lesser extent NE. Dopamine lesions to the mPFC resulted in a trend
toward increased omissions and reduced correct responses, particularly at more challenging
stimulus durations. However, these depletions did not significantly impair rats’ performance in
the 5-CSRTT.
The lack of effect of 6-OHDA in the present study is surprising given the role of DA and
cognition in the PFC (Goldman-Rakic, Muly, & Williams, 2000). A trend toward poorer
performance in 6-OHDA treated animals suggests that the nonsignificant results are attributable
to small group sizes or lack of sensitivity in the 5-CSRTT to detect attentional dysfunction in
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lesioned rats. Alternately, when rats sustain combined NE and DA loss in the mPFC,
extracellular DA concentrations in the mPFC were not different from controls (Venator, Lewis,
& Finlay, 1999). It has been suggested that in the absence of NE reuptake proteins to clear
extracellular DA, concentrations of DA in the synapse are maintained at normal levels.
Quinolinic acid lesions of the mPFC, but not the parietal or cingulate cortex, impair 5CSRTT performance, suggesting that sustained attention assessed by this task is dependent on
the mPFC (Muir, Everitt, & Robbins, 1996). By contrast, in the present study behavioral deficits
were not observed despite significant catecholamine depletion in the mPFC. The goal of 6OHDA induced DA depletion of the mPFC in the present study was to mimic the type of DA
disruption seen in post-mortem analyses of schizophrenics (Akil et al., 1999). However, it is
possible that 6-OHDA neurotoxic effects are not enough to functionally impair rats in the 5CSRTT compared to those with mPFC quinolinic acid lesions, which affects predominantly
glutamatergic and GABAergic neurotransmission in lesioned brain regions (Scharcz, Whetsell,
& Mangano, 1983).
Inherent variability in rats’ ability in the 5-CSRTT may have diminished the likelihood of
detecting group differences in the present study, particularly in light of small group sizes. Granon
et al. (2000) found that administration of the D1 agonist SCH 38393 into the mPFC improved
accuracy in rats categorized as exhibiting lower baseline accuracy (<75% correct at a stimulus
duration of 0.5 seconds). Alternately, antagonism of D1 receptors using SCH 23390 impaired
accuracy in rats exhibiting higher baseline accuracy (>75% correct at stimulus durations between
0.5 and 0.25 seconds). The different responses to dopaminergic pharmacological manipulation
between high and low performing rats suggests that DA activity in the mPFC may be vary due to
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differences in endogenous DA neurotransmission in low- and high-performing rats. Likewise,
behavioral deficits in the 5-CSRTT due to DA depletions may not be detected when rats innately
performing at different levels are treated equally. Future studies might train rats in the 5-CSRTT
prior to surgical manipulation in order to separate low- and high-performing rats before assessing
the behavioral effects of 6-OHDA lesions. This would require larger sample sizes than those
used in the present study.
The trend toward increased omissions in the lesioned group emerged in four out of five
testing sessions, and was observed in trials with the shortest stimulus durations (0.5 and 0.25
seconds). Taking this into account, the trend toward performance deficit under challenging task
circumstances should be explored in future studies utilizing 6-OHDA lesions at even shorter
durations (ie., 0.10 and 0.05 seconds). It is possible that the baseline and limited stimulus
durations used in the present study (2.5, 1.5, 1.0, 0.5, and 0.25 seconds) did not provide the
challenge necessary to detect attentional dysfunction in DA depleted rats.
Another methodological consideration is that the 5-CSRTT testing session lasts for 100
trials or 30 minutes, whichever is longer. As the rats learn to perform at a criterion of >80%
correct and <20% omitted responses at a 2.5 second stimulus duration, in nearly all animals the
length of the testing session was “timed out,” meaning that the animals reached 100 trials before
30 minutes. In many cases, the length was cut almost in half. Future studies could test
performance in the 5-CSRTT if rats were required to maintain vigilant for the full 30 minutes
under challenging testing conditions with shortened stimulus durations.
In the current study, the NE transporter antagonist DMI was administered to prevent 6OHDA from damaging NE-containing neurons. Unexpectedly, 6-OHDA-treated animals
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sustained ~50% NE depletion in addition to ~67% DA depletion in the mPFC. In previous work,
administration of 6-OHDA using a similar protocol decreased NE tissue concentrations by 1535% (e.g., Venator, Lewis, & Finlay, 1999). Given the larger NE depleting in the present study,
it is possible that less NE in the mPFC resulted in masking the DA depletion resulting from 6OHDA. The reasons for greater NE loss in the present study are unclear, but one possibility is
that the batch of DMI used was ineffective for unknown reasons. Despite this unresolved issue,
catecholamine depletion did not produce deficits on 5-CSRTT performance.
The aim of this thesis was to study the effects of DA depletions in the mPFC of rats on
sustained attention performance. Trends toward poorer performance in lesioned animals should
be explored in future studies with larger sample sizes. These trends support a possible role of DA
and NE in the mPFC in modulating sustained attention while having no effect on impulsivity,
consistent with other reports of DA agonists affecting response selection and not premature
responding (Passetti, Dalley, & Robbins, 2003).
The trend in results suggests that DA in the PFC may play a role in attentional
dysfunction in schizophrenia. Schizophrenia may involve imbalance of DA neurotransmission of
cortical and subcortical sites, posing a challenge in developing pharmaceutical treatments. This
challenge is further compounded by the heterogeneity of symptoms in schizophrenia, as both
psychotic symptoms and cognitive deficits have considerable detriments in occupational and
social settings. Unfortunately, current pharmacological therapy is primarily used to treat
psychotic symptoms, and does not directly address the cognitive deficits (Wassef, Dott, Harris,
Brown, O’Boyle, Meyer, et al., 1999). Complex interactions both within DA systems and
between DA and other neurotransmitter systems in the PFC remain to be elucidated. Further
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research is needed in order to elucidate the possible role of DA in cognitive deficits, and to
develop pharmacotherapy to DA pathways under conditions of both possible DA hyper- and
hypoactivity.
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Table 1. Means and standard deviations of mPFC tissue dopamine (DA), norepinephrine (NE),
assayed by high-pressure liquid chromatography.

Relative Concentrations (expressed as ng/mg tissue wet weight)
DA

NE

______________________________________________________________________________
6-OHDA (n=6)

0.04 (0.02)**

0.25 (0.08)**

Control (n=5)

0.13 (0.01)

0.48 (0.05)

** p < .001
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Table 2. Means and standard deviations of correct responses of 6-OHDA treated and sham
control rats.

Stimulus Duration (seconds)
2.5

1.5

1.0

0.5

0.25

______________________________________________________________________________
6-OHDA (n=6)

83.3 ± 5.5

69.2 ± 7.4

64.3 ± 6.7

36.9 ± 10.9

18.1 ± 5.1

Control (n=5)

83.8 ± 3.9

75.6 ± 8.5

64.7 ± 8.2

41.7 ± 5.5

23.9 ± 6.6

Total

83.6 ± 4.6

72.1 ± 8.2

64.5 ± 12.9

39.1 ± 8.8

20.7 ± 6.3

______________________________________________________________________________
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Table 3. Means and standard deviations of omitted responses of 6-OHDA treated and sham
control rats.

Stimulus Duration (seconds)
2.5

1.5

1.0

0.5

0.25

______________________________________________________________________________
6-OHDA
Control
Total

9.6 ± 4.4

18.7 ± 8.3

23.0 ± 15.7

37.8 ± 15.5

50.3 ± 13.7

10.0 ± 4.1

12.1 ± 7.7

20.3 ± 11.2

29.0 ± 7.3

40.0 ± 12.5

9.8 ± 4.1

15.7 ± 8.4

21.8 ± 13.2

33.8 ± 12.7

45.6 ± 13.6

______________________________________________________________________________
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Table 4. Means and standard deviations of incorrect responses of 6-OHDA treated and control
rats.
______________________________________________________________________________
Stimulus Duration (seconds)
2.5

1.5

1.0

0.5

0.25

______________________________________________________________________________
6-OHDA (n=6)

4.0 ± 3.2

7.3 ± 4.2

8.2 ± 6.1

16.4 ± 7.8

20.1 ± 8.2

Control (n=5)

3.5 ± 2.3

7.7 ± 5.0

10.4 ± 5.8

19.8 ± 6.4

25.3 ± 8.3

Total

3.8 ± 2.7

7.5 ± 4.3

9.2 ± 5.7

18.0 ± 7.0

22.5 ± 8.3

______________________________________________________________________________
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Table 5. Means and standard deviations of premature responses of 6-OHDA treated and control
rats.

Stimulus Duration (seconds)
2.5

1.5

1.0

0.5

0.25

______________________________________________________________________________
6-OHDA (n=6)

3.1 ± 2.4

4.7 ± 1.0

4.4 ± 2.2

8.9 ± 2.7

11.6 ± 3.8

Control (n=5)

2.7 ± 2.6

4.3 ± 4.2

4.6 ± 4.1

9.5 ± 4.0

10.9 ± 5.8

Total

2.9 ± 2.4

4.5 ± 2.7

4.5 ± 3.0

9.2 ± 3.2

11.2 ± 4.8

______________________________________________________________________________
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Figure Captions
Figure 1. Possible responses in the 5-choice serial reaction time task over the 30-minute testing
session. (Dalley, Cardinal, & Robbins, 2004).
Figure 2. Percent correct* responses in control and 6-OHDA treated animals (error bars =
S.E.M.). *% Correct = # Correct / Correct + Incorrect
Figure 3. Percent omissions* in control and 6-OHDA treated animals (error bars = S.E.M.).
*% Omitted = # Omissions / Omissions + Correct + Incorrect
Figure 4. Number of premature responses in control and 6-OHDA treated animals (error bars =
S.E.M.).
Figure 5. Number of incorrect responses in control and 6-OHDA treated animals (error bars =
S.E.M.).
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